Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Semlali, Abdelhabib ^a,b   Killer, Kerstin ^a   Alanazi, Humidah ^a   Chmielewski, Witold ^a   Rouabhia, Mahmoud ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Adhesion; Biofilm; C albicans; Cigarette smoke; EAP 1; Genes; Growth; HWP 1; Sap2; Tobacco

Indexed keywords

ASPARTIC PROTEINASE; CIGARETTE SMOKE CONDENSATE; EAP1 PROTEIN; FUNGAL PROTEIN; HYPHAL WALL PROTEIN 1; MESSENGER RNA; SAP2 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE 2; CELL MEMBRANE PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ANIMAL CELL; ARTICLE; BIOFILM; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGAL GENE; FUNGAL STRAIN; FUNGUS GROWTH; GENE EXPRESSION; MICROBIAL ADHESION; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; YEAST CELL; CONCENTRATION (PARAMETERS); GENE ACTIVATION; GENE CONTROL; INCUBATION TIME; MUCOADHESION; OPTICAL DENSITY;

BACTERIA (MICROORGANISMS); NICOTIANA TABACUM;

ASPARTIC ACID ENDOPEPTIDASES; BACTERIA; BIOFILMS; CANDIDA ALBICANS; CELL ADHESION; FUNGAL PROTEINS; GENE EXPRESSION; MEMBRANE GLYCOPROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; SMOKE; SMOKING; TOBACCO PRODUCTS; TRANSCRIPTION FACTORS;

EID: 84899098786     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-61     Document Type: Article

References (53)

1. Changing epidemiology of systemic fungal infections. Richardson M, Lass-Florl C, Clin Microbiol Infect 2008 14 5 24
2. Regulation of multidrug resistance in pathogenic fungi. Morschhauser J, Fungal Genet Biol 2010 47 94 106 10.1016/j.fgb.2009.08.002 19665571
3. Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Rouabhia M, Ross G, Page N, Chakir J, Infect Immun 2002 70 7073 7080 10.1128/IAI.70.12.7073-7080.2002 12438388
4. Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases. Rouabhia M, Schaller M, Corbucci C, Vecchiarelli A, Prill SK, Giasson L, Ernst JF, Infect Immun 2005 73 4571 4580 10.1128/IAI.73.8.4571-4580.2005 16040968
5. Cellular and molecular mechanisms of resistance to oral Candida albicans infections. Saunus JM, Kazoullis A, Farah CS, Front Biosci 2008 13 5345 5358 18508591
6. Transcriptional responses of Candida albicans to epithelial and endothelial cells. Park H, Liu Y, Solis N, Eukaryot Cell 2009 8 1498 1510 10.1128/EC.00165-09 19700637
7. In vivo transcript profiling of Candida albicans identifies a gene essential for inter-epithelial dissemination. Zakikhany K, Naglik JR, Schmidt-Westhausen A, Holland G, Schaller M, Hube B, Cell Microbiol 2007 9 2938 2954 10.1111/j.1462-5822.2007.01009.x 17645752
8. Bacterial biofilms: a common cause of persistent infections. Costerton JWS, Stewart PS, Greenberg EP, Science 1999 284 1318 1322 10.1126/science.284. 5418.1318 10334980
9. Persistent bacterial infections, antibiotic tolerance, and the oxidative stress response. Grant SS, Hung DT, Virulence 2013 4 273 283 10.4161/viru.23987 23563389
10. Adhesion in Candida spp. Sundstrom P, Cell Microbiol 2002 4 461 469 10.1046/j.1462-5822.2002.00206.x 12174081
11. Function of Candida albicans adhesin Hwp1 in biofilm formation. Nobile CJ, Nett JE, Andes DR, Mitchell AP, Eukaryot Cell 2006 5 1604 1610 10.1128/EC.00194-06 17030992
12. EAP1, a Candida albicans gene involved in binding human epithelial cells. Li F, Palecek SP, Eukaryot Cell 2003 2 1266 1273 10.1128/EC.2.6.1266-1273.2003 14665461
13. EFG1 is a major regulator of cell wall dynamics in Candida albicans as revealed by DNA microarrays. Sohn K, Urban C, Brunner H, Rupp S, Mol Microbiol 2003 47 89 102 12492856
14. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. Stoldt VR, Sonneborn A, Leuker CE, Ernst JF, EMBO J 1997 16 1982 1991 10.1093/emboj/16.8.1982 9155024
15. Nonfilamentous C albicans mutants are avirulent. Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR, Cell 1997 90 939 949 10.1016/S0092-8674(00)80358-X 9298905
16. Hydrolytic enzymes as virulence factors of Candida albicans. Schaller M, Borelli C, Korting HC, Hube B, Mycoses 2005 48 365 377 10.1111/j.1439-0507.2005. 01165.x 16262871
17. Farnesol, a fungal quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes. Décanis N, Tazi N, Correia A, Vilanova M, Rouabhia M, Open Microbiol J 2011 5 119 126 10.2174/1874285801105010119 22207890
18. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Naglik JR, Challacombe SJ, Hube B, Microbiol Mol Biol Rev 2003 67 400 428 10.1128/MMBR.67.3.400-428.2003 12966142
19. Candida albicans proteinases: resolving the mystery of a gene family. Hube B, Naglik J, Microbiology 2001 147 1997 2005 11495978
20. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. White TC, Agabian N, J Bacteriol 1995 177 5215 5221 7665510
21. Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. Albrecht A, Felk A, Pichova I, Naglik JR, Schaller M, de Groot P, Maccallum D, Odds FC, Schäfer W, Klis F, Monod M, Hube B, J Biol Chem 2006 281 688 694 10.1074/jbc.M509297200 16269404
22. From inhaler to lung: clinical implications of the formulations of ciclesonide and other inhaled corticosteroids. Nave R, Mueller H, Int J Gen Med 2013 6 99 107 23516175
23. Oropharyngeal candidiasis and radiotherapy. Pinel B, Cassou-Mounat T, Bensadoun RJ, Cancer Radiother 2012 3 222 229
24. Candida-host interactions in HIV disease: implications for oropharyngeal candidiasis. Fidel PL Jr, Adv Dent Res 2011 1 45 49
25. Enhancement of Candida albicans virulence after exposition to cigarette mainstream smoke. Baboni FB, Barp D, Izidoro AC, Samaranayake LP, Rosa EA, Mycopathologia 2009 168 5 227 235 10.1007/s11046-009-9217-5 19544010
26. The impact of cigarette/tobacco smoking on oral candidosis: an overview. Soysa NS, Ellepola AN, Oral Dis 2005 5 268 273
27. Tobacco smoke mediated induction of sinonasal microbial biofilms. Goldstein-Daruech N, Cope EK, Zhao KQ, Vukovic K, Kofonow JM, Doghramji L, González B, Chiu AG, Kennedy DW, Palmer JN, Leid JG, Kreindler JL, Cohen NL, PLoS One 2011 6 15700 10.1371/journal.pone.0015700 21253587
28. Influence of cigarette smoke condensate on cariogenic and candidal biofilm formation on orthodontic materials. Baboni FB, Guariza Filho O, Moreno AN, Rosa EA, Am J Orthod Dentofacial Orthop 2010 4 427 434
29. Effects of cigarette smoke on salivary protein tyrosine nitration. Weiner D, Khankin EV, Levy Y, Aizenbud D, Reznick AZ, Eur J Med Res 2010 2 211 216
30. The prevalence of Candida albicans populations in the mouths of complete denture wearers. Abu-Elteen KH, Abu-Alteen RM, New Microbiol 1998 21 1 41 48 9497928
31. Oral candidal carriage and infection in insulin-treated diabetic patients. Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ, Diabet Med 1999 16 8 675 679 10.1046/j.1464-5491.1999.00134.x 10477213
32. Influence of nicotine and cotinine on epithelial colonization by periodontopathogens. Teughels W, Van Eldere J, van Steenberghe D, Cassiman JJ, Fives-Taylor P, Quirynen M, J Periodontol 2005 8 1315 1322
33. Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems. Feldman C, Anderson R, J Infect 2013 3 169 184
34. Cigarette smoke vapor-phase effects on the rat upper respiratory tract. Gaworski CL, Dozier MM, Eldridge SR, Morrissey R, Rajendran N, Gerhart JM, Inhalation Toxicol 1998 10 857 873 10.1080/089583798197420
35. Quantitative puff-by-puff-resolved characterization of selected toxic compounds in cigarette mainstream smoke. Adam T, Mitschke S, Streibel T, Baker RR, Zimmermann R, Chem Res Toxicol 2006 19 511 520 10.1021/tx050220w 16608162
36. In vitro efficacy of nisin Z against Candida albicans adhesion and transition following contact with normal human gingival cells. Akerey B, Le-Lay C, Fliss I, Subirade M, Rouabhia M, J Appl Microbiol 2009 107 1298 1307 10.1111/j.1365-2672.2009.04312.x 19486401
37. Disruption of the GPI protein-encoding gene IFF4 of Candida albicans results in decreased adherence and virulence. Kempf M, Cottin J, Licznar P, Lefrançois C, Robert R, Apaire-Marchais V, Mycopathologia 2009 168 73 77 10.1007/s11046-009-9201-0 19347602
38. Portrait of Candida albicans adherence regulators. Finkel JS, Xu W, Huang D, Hill EM, Desai JV, Woolford CA, Nett JE, Taff H, Norice CT, Andes DR, Lanni F, Mitchell AP, PLoS Pathog 2012 2 1002525
39. Improved gene ontology annotation for biofilm formation, filamentous growth, and phenotypic switching in Candida albicans. Inglis DO, Skrzypek MS, Arnaud MB, Binkley J, Shah P, Wymore F, Sherlock G, Eukaryot Cell 2013 12 1 101 108 10.1128/EC.00238-12 23143685
40. Adherence and biofilm formation of non-Candida albicans Candida species. Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J, Trends Microbiol 2011 19 5 241 247 10.1016/j.tim.2011.02.003 21411325
41. Cigarette smoke increases staphylococcus aureus biofilm formation via oxidative stress. Kulkarni R, Antala S, Wang A, Amaral FE, Rampersaud R, Larussa SJ, Planet PJ, Ratner AJ, Infect Immun 2012 80 11 3804 3811 10.1128/IAI.00689-12 22890993
42. Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin. Mutepe ND, Cockeran R, Steel HC, Theron AJ, Mitchell TJ, Feldman C, Anderson R, Eur Respir J 2013 41 2 392 395 10.1183/09031936.00213211 22743667
43. Tobacco smoke augments porphyromonas gingivalis-streptococcus gordonii biofilm formation. Bagaitkar J, Daep CA, Patel CK, Renaud DE, Demuth DR, Scott DA, PLoS One 2011 6 11 27386 10.1371/journal.pone.0027386 22110637
44. The NDR/LATS kinase Cbk1 controls the activity of the transcriptional regulator Bcr1 duringbiofilm formation in Candida albicans. Gutiérrez- Escribano P, Zeidler U, Suárez MB, Bachellier-Bassi S, Clemente-Blanco A, Bonhomme J, de Aldana CR V, d'Enfert C, Correa-Bordes J, PLoS Pathog 2012 8 5 1002683 10.1371/journal.ppat.1002683 22589718
45. Disruption of the ECM33 gene in Candida albicans prevents biofilm formation, engineered human oral mucosa tissue damage and gingival cell necrosis/apoptosis. Rouabhia M, Semlali A, Chandra J, Mukherjee P, Chmielewski W, Ghannoum MA, Mediators Inflamm 2012 2012 398207 22665950
46. Eap1p, an adhesin that mediates Candida albicans biofilm formation in vitro and in vivo. Li F, Svarovsky MJ, Karlsson AJ, Wagner JP, Marchillo K, Oshel P, Andes D, Palecek SP, Eukaryot Cell 2007 6 931 939 10.1128/EC.00049-07 17416898
47. HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. Sharkey LL, McNemar MD, Saporito-Irwin SM, Sypherd PS, Fonzi WA, J Bacteriol 1999 181 5273 5279 10464197
48. Simple method for screening Candida species isolates for the presence of secreted proteinases: a tool for the prediction of successful inhibitory treatment. Dostál J, Hamal P, Pavlícková L, Soucek M, Ruml T, Pichová I, Hrusková-Heidingsfeldová O, J Clin Microbiol 2003 41 2 712 716 10.1128/JCM.41.2.712-716.2003 12574271
49. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Kantarcioglu AS, Yücel A, Mycoses 2002 45 5-6 160 165 12100532
50. Degradation of humoral host defense by Candida albicans proteinase. Kaminishi H, Miyaguchi H, Tamaki T, Suenaga N, Hisamatsu M, Mihashi I, Matsumoto H, Maeda H, Hagihara Y, Infect Immun 1995 63 984 988 7868271
51. Antagonistic effect of Candida albicans and IFNγ on E-cadherin expression and production by human primary gingival epithelial cells. Rouabhia M, Semlali A, Audoy J, Chmielewski W, Cell Immunol 2012 280 1 61 67 10.1016/j.cellimm.2012.11.008 23261830
52. Candida albicans proteinases and host/pathogen interactions. Naglik J, Albrecht A, Bader O, Hube B, Cell Microbiol 2004 6 10 915 926 10.1111/j.1462-5822.2004.00439.x 15339267
53. Human serum promotes Candida albicans biofilm growth and virulence gene expression on silicone biomaterial. Samaranayake YH, Cheung BP, Yau JY, Yeung SK, Samaranayake LP, PLoS One 2013 8 5 62902 10.1371/journal.pone.0062902 23704884